Polyrizon Ltd.

Nasdaq:PLRZ

Surgical & Medical Instruments & Apparatus·RA'ANANA

Summary Financials

Revenue

—

Adj. EBITDA

-$890,000

FY 2024

Net Income

-$779,000

FY 2024

EPS (Diluted)

$0.60

FY 2024

Stock Price

$13.70

+1.5%

2026-03-20

52W Range

$2.88 – $2235.00

P/E Ratio

22.8x

Market Cap

$57.5M

Cash

$4,000

FY 2024

Total Debt

—

Net Cash

$4,000

Enterprise Value

$57.5M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-64.6x

Employees

—

Revenue

—

Adj. EBITDA

-$890,000

FY 2024

Net Income

-$779,000

FY 2024

EPS (Diluted)

$0.60

FY 2024

Stock Price

$13.70

+1.5%

2026-03-20

52W Range

$2.88 – $2235.00

P/E Ratio

22.8x

Market Cap

$57.5M

Cash

$4,000

FY 2024

Total Debt

—

Net Cash

$4,000

Enterprise Value

$57.5M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-64.6x

Employees

—